# Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis

> **NCT00886925** · PHASE4 · COMPLETED · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 56 (actual)

## Conditions studied

- Hepatic Encephalopathy

## Interventions

- **DRUG:** Albumin
- **DRUG:** Sodium chloride 0.9%

## Key facts

- **NCT ID:** NCT00886925
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2012-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00886925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00886925, "Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00886925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*